These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16100770)

  • 1. Calpainopathy (LGMD2A) in Croatia: molecular and haplotype analysis.
    Milic A; Canki-Klain N
    Croat Med J; 2005 Aug; 46(4):657-63. PubMed ID: 16100770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the 550delA mutation in calpainopathy (LGMD 2A) in Croatia.
    Canki-Klain N; Milic A; Kovac B; Trlaja A; Grgicevic D; Zurak N; Fardeau M; Leturcq F; Kaplan JC; Urtizberea JA; Politano L; Piluso G; Feingold J
    Am J Med Genet A; 2004 Mar; 125A(2):152-6. PubMed ID: 14981715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of 550delA mutation of CAPN3 in LGMD2 patients from Russia.
    Pogoda TV; Krakhmaleva IN; Lipatova NA; Shakhovskaya NI; Shishkin SS; Limborska SA
    Hum Mutat; 2000 Mar; 15(3):295. PubMed ID: 10679950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark.
    Duno M; Sveen ML; Schwartz M; Vissing J
    Eur J Hum Genet; 2008 Aug; 16(8):935-40. PubMed ID: 18337726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.
    Sáenz A; Leturcq F; Cobo AM; Poza JJ; Ferrer X; Otaegui D; Camaño P; Urtasun M; Vílchez J; Gutiérrez-Rivas E; Emparanza J; Merlini L; Paisán C; Goicoechea M; Blázquez L; Eymard B; Lochmuller H; Walter M; Bonnemann C; Figarella-Branger D; Kaplan JC; Urtizberea JA; Martí-Massó JF; López de Munain A
    Brain; 2005 Apr; 128(Pt 4):732-42. PubMed ID: 15689361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calpain-3 gene defect causing limb gird muscular dystrophy in a Hungarian family].
    Horváth R; Walter MC; Lochmüller H; Hübner A; Karcagi V; Pikó H; Timár L; Komoly S
    Ideggyogy Sz; 2005 Jan; 58(1-2):52-8. PubMed ID: 15884399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of CAPN3 transcripts in LGMD2A patients: involvement of nonsense-mediated mRNA decay.
    Stehlíková K; Zapletalová E; Sedlácková J; Hermanová M; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Vohánka S; Fajkus J; Fajkusová L
    Neuromuscul Disord; 2007 Feb; 17(2):143-7. PubMed ID: 17157502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Frequency of c.550delA Mutation of the CANP3 Gene in the Polish LGMD2A Population.
    Dorobek M; Ryniewicz B; Kabzińska D; Fidziańska A; Styczyńska M; Hausmanowa-Petrusewicz I
    Genet Test Mol Biomarkers; 2015 Nov; 19(11):637-40. PubMed ID: 26484845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional explorations of CAPN3 identify novel splicing mutations, a large-sized genomic deletion and evidence for messenger RNA decay.
    Krahn M; Pécheux C; Chapon F; Béroud C; Drouin-Garraud V; Laforet P; Romero NB; Penisson-Besnier I; Bernard R; Urtizberea JA; Leturcq F; Lévy N
    Clin Genet; 2007 Dec; 72(6):582-92. PubMed ID: 17979987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
    Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
    Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.
    Hermanová M; Zapletalová E; Sedlácková J; Chrobáková T; Letocha O; Kroupová I; Zámecník J; Vondrácek P; Mazanec R; Maríková T; Vohánka S; Fajkusová L
    Muscle Nerve; 2006 Mar; 33(3):424-32. PubMed ID: 16372320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of calpain-3 c.550delA mutation in limb girdle muscular dystrophy type 2 and isolated hyperCKemia in German patients.
    Hanisch F; Müller CR; Grimm D; Xue L; Traufeller K; Merkenschlager A; Zierz S; Deschauer M
    Clin Neuropathol; 2007; 26(4):157-63. PubMed ID: 17702496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAPN3 mutations in patients with idiopathic eosinophilic myositis.
    Krahn M; Lopez de Munain A; Streichenberger N; Bernard R; Pécheux C; Testard H; Pena-Segura JL; Yoldi E; Cabello A; Romero NB; Poza JJ; Bouillot-Eimer S; Ferrer X; Goicoechea M; Garcia-Bragado F; Leturcq F; Urtizberea JA; Lévy N
    Ann Neurol; 2006 Jun; 59(6):905-11. PubMed ID: 16607617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of myotonic dystrophy in Istria: molecular genetic approach. Part II: Analysis of genetic polymorphisms.
    Medica I; Logar N; Peterlin B
    Coll Antropol; 2000 Dec; 24(2):287-94. PubMed ID: 11216395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients.
    Alavi A; Elahi E; Tehrani MH; Amoli FA; Javadi MA; Rafati N; Chiani M; Banihosseini SS; Bayat B; Kalhor R; Amini SS
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4490-7. PubMed ID: 17898270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of phenylalanine hydroxylase deficiency in Croatia.
    Zschocke J; Preusse A; Sarnavka V; Fumic K; Mardesic D; Hoffmann GF; Baric I
    Hum Mutat; 2003 Apr; 21(4):399. PubMed ID: 12655552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpain-3 mutations in Turkey.
    Balci B; Aurino S; Haliloglu G; Talim B; Erdem S; Akcören Z; Tan E; Caglar M; Richard I; Nigro V; Topaloglu H; Dincer P
    Eur J Pediatr; 2006 May; 165(5):293-8. PubMed ID: 16411092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage Study Revealed Complex Haplotypes in a Multifamily due to Different Mutations in CAPN3 Gene in an Iranian Ethnic Group.
    Mojbafan M; Tonekaboni SH; Abiri M; Kianfar S; Sarhadi A; Nilipour Y; Tavakkoly-Bazzaz J; Zeinali S
    J Mol Neurosci; 2016 Jul; 59(3):392-6. PubMed ID: 27262448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.